Karen Pendergrass, Standards Team

This literature review maps the microbiome signature of endometriosis across multiple body sites, revealing distinct taxa enriched or depleted in patients compared to controls, highlighting microbial shifts by disease stage, site, and taxa.

Microbiome findings provide mechanistic insights into how chlorhexidine (CHX) mouthwash might contribute to breast cancer and breast disease in a causal manner.

The chronic inflammatory state of endometriosis affects energy metabolism, particularly altering glutamine and glutamate levels in tissues. These shifts in amino acid, lipid, sugar, and organic acid metabolisms create a distinct profile for endometriosis.

Metronidazole is a validated microbiome-targeted intervention (MBTI) for endometriosis, reducing key dysbiotic taxa and suppressing inflammation and lesion progression.

HBOT demonstrates complete remission and holds significant promise as a candidate for microbiome-targeted intervention for endometriosis.

A low-nickel diet is validated as an MBTI for endometriosis because it disrupts nickel-dependent pathogens, rebalances the microbiome, and improves symptoms like pelvic pain and dysmenorrhea.

By directly targeting microbial dysbiosis, hormonal imbalances, and inflammation, metformin not only validates the clinical relevance of the endometriosis microbiome signature but also positions itself as an effective therapeutic option for the condition.

Pueraria Flower Extract (PFE) addresses microbial imbalances and inflammation in endometriosis, validating its role as a microbiome-targeted therapy.

Overview A microbiome specialist is a healthcare or research professional with expertise in the human microbiome—the diverse community of microorganisms that inhabit multiple body sites, including the gastrointestinal tract, skin, oral cavity, and genitourinary system. These specialists investigate how microbial ecosystems influence human physiology, disease risk, and treatment response, and they translate microbiome science into […]

Your microbiome is the collection of microorganisms (such as bacteria, fungi, and viruses) that live on and in your body. It is unique to you and can be influenced by various factors, including your diet, environment, and genetics. Determining your own unique Microbiome Signature can be performed by undergoing microbiome testing. This can be done […]

This review explains how the gut microbiota prevents Salmonella infection through metabolic competition, antimicrobial activity, and immune regulation, highlighting colonization resistance as a key defense against enteric pathogens.

Chronic chlorpyrifos exposure induces obesity and insulin resistance by altering gut microbiota, increasing gut permeability, and driving inflammation.

This review highlights the role of prebiotics in modulating gut microbiota, enhancing gut health, and alleviating conditions like obesity and IBD. It emphasizes the benefits of prebiotics like inulin and FOS and introduces the concept of synbiotics, combining prebiotics and probiotics for optimal gut health.

This review unifies Parkinson’s disease mechanisms under a single framework of heavy metal-induced ferroptosis, microbial virulence, and α-synuclein aggregation, emphasizing the central role of metal-driven dysbiosis and gut-brain axis propagation.

The Microbial Metallomics Theory of Parkinson’s Disease, as a unified disease-specific framework integrating ferroptosis, microbial dysbiosis, metallomic selection, and α-synuclein pathology, is credited to Karen Pendergrass.

This review maps the immune‑microbial mechanisms driving Graves’ disease and evaluates next‑generation biologics, small molecules and tolerance‑inducing peptides that may replace conventional ablation therapies.

What was reviewed? This review article examined the therapeutic potential of minocycline, a second-generation tetracycline antibiotic, as a neuroprotective agent in Parkinson’s disease (PD). The authors synthesized data from 92 selected sources, including preclinical studies, clinical trials, and review articles, to assess the capacity of minocycline to modify disease progression through its anti-inflammatory, anti-apoptotic, and […]

This paper proposes that Parkinson’s disease vulnerability is partly a pigment and metal-handling problem. MC1R loss-of-function biases neuromelanin toward pheomelanin-like subunits, weakening iron sequestration and amplifying oxidative stress. We argue that MC1R agonists, including melanotan peptides, could restore eumelanin-like buffering, reduce ferroptosis, and dampen neuroinflammation.

The environmental theory of endometriosis suggests exposure to toxins like dioxins and PCBs may contribute to its development by disrupting hormones, modulating the immune system, and promoting inflammation.

This review integrates ecological and immunological data on microbiome-based-interventions, linking specific taxa, diets, and microbial metabolites to gut community shifts, barrier function, and adaptive immunity, and outlining translational opportunities and risks for clinically targeted microbiome modulation.

A 4-week prebiotic diet in PD patients increased faecal SCFAs, improved gut-brain metabolite profiles, and alleviated gastrointestinal symptoms, but core dysbiosis persisted. Results support microbiota-directed dietary interventions as a promising adjunct for Parkinson’s management.

Parkinson’s disease may be best explained as a metal-driven disorder in which heavy metal and pesticide exposures initiate iron dysregulation, ferritinophagy, and ferroptosis, while simultaneously selecting for metal-resistant gut pathobionts that amplify inflammation, barrier failure, and α-synuclein seeding. This unifies dysbiosis, neuroinflammation, and proteinopathy into one upstream metallomic framework.

This hypothesis reframes the red hair MC1R–Parkinson’s link as a metal-handling phenotype. Pheomelanin-biased neuromelanin may lose eumelanin casing capacity, saturate with iron earlier, release labile iron, and amplify ROS and ferroptosis in dopaminergic neurons, yielding a modifiable risk target.

This review explores siderophore-mediated iron acquisition in the gut, its role in bacterial growth, and its impact on microbial community dynamics and host immunity, with implications for IBD, infections, and colorectal cancer.